How do you decide on rate versus rhythm control?

Similar documents
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015

How should we treat atrial fibrillation in heart failure

Management of Symptomatic Atrial Fibrillation

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

Recurrent AF: Choosing the Right Medication.

Atrial Fibrillation An update on diagnosis and management

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Presenter Disclosure Information

Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy

Management of Atrial Fibrillation in Heart Failure

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Managing the Patient with Atrial Fibrillation

Atrial Fibrillation The Basics

A 35 yo female presents increasing fatigue and shortness of breath for several days. She is found to be in atrial fibrillation.

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

Updated Cardiac Resynchronization Therapy Guidelines

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?

Atrial Fibrillation (AF) March, 2013

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin

A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

DISCLOSURES. I am a consultant for Biosense Webster St Jude Medical

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

Raising Sleep Apnea Awareness:

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

9/5/14. Objectives. Atrial Fibrillation (AF)

Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist

PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia

The intensity and duration of monitoring should be determined by the clinical need to establish the diagnosis

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Does Depression affect compliance with CPAP therapy in patients with Obstructive Sleep Apnea? Ramesh Metta, MBBS M Jeffery Mador, MD

New in Atrial Fibrillation

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

A focus on atrial fibrillation

Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014

What Can I Do about Atrial Fibrillation (AF)?

Il loop recorder esterno. Roberto Maggi

What Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation?

Disclosures. Anesthesia and Lead Extractions. Lead Extractions: Objectives. Lead Removal Techniques. None

Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

Surgeons Role in Atrial Fibrillation

How To Improve Health Care For Remote Workers

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

New Approaches to Anticoagulation in Atrial Fibrillation

Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs

Dorset Cardiac Centre

Atrial Fibrillation Management Across the Spectrum of Illness

Xarelto (Rivaroxaban)

Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey

on behalf of the AUGMENT-HF Investigators

INHERIT. The Lancet Diabetes & Endocrinology In press

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial

The debate: Should all AF patients see an EP consultant?

Efficacy and Safety of Pharmacological Options for Rate Control in Atrial Fibrillation

ACUTE ATRIAL FIBRILLATION TREATMENT IN THE SURGICAL PATIENT

Anticoagulation before and after cardioversion; which and for how long

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Non- Valvular Atrial Fibrillation and Stroke Prevention: Which OAC Do I Choose. Warfarin vs the NOACs

HEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: DIAGNOSIS OF SLEEP APNEA IN ADULTS DATE: 5/9/2013 HERC COVERAGE GUIDANCE

Establishing a Remote Monitoring Program. Martha Ferrara, FNP

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April Reference: NHSCB/A09/PS/b

RR 0.88 (95% CI: ) P=0.051 (superiority) 3.75

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial fibrillation How is treatment changing? Charles Henrikson, MD Director, Electrophysiology Service 1 February 2014

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Transcription:

Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist

Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study 2002 RACE study 2002 Catheter ablation CABANA trial Define outcome measure Symptomatic benefit Mortality or morbidity reduction

A COMPARISON OF RATE CONTROL AND RHYTHM CONTROL IN PATIENTS WITH ATRIAL FIBRILLATION 14 (0.006%) of 2033 in the rhythm control group underwent catheter ablation SR conferred a 53% mortality reduction AAD conferred a 49% mortality increase The AFFIRM investigators; N Engl J Med, Vol. 347, No. 23

A COMPARISON OF RATE CONTROL AND RHYTHM CONTROL IN PATIENTS WITH RECURRENT PERSISTENT ATRIAL FIBRILLATION The RACE study group Van Gelder et al N Engl J Med 2002;347:1834-40

Maintenance of Sinus Rhythm with an ablation strategy in patients with AF is associated with a lower risk of stroke and death Hunter et Al, Heart 2011

Asymptomatic persistent AF and outcome: Results of the RACE study Rienstra et al, Heart Rhythm, Vol 11, June 2014

Nice 2014: When to offer rate or rhythm control? Offer rate control in people with AF except where: There is a reversible cause Heart failure is felt secondary to AF New onset AF Atrial flutter For whom a rhythm control strategy is deemed more suitable based upon clinical judgement

June 2014

ESC guidelines ESC Guidelines for the management of atrial fibrillation Europace (2010)

Long term follow up after ablation of longstanding PsAF Rostock et al, Heart Rhythm Vol 9, 2011 Tilz et al, Jacc Vol 60; 2012

For whom a rhythm control strategy is deemed more suitable based upon clinical judgement Who benefits most from rhythm control? Procedural risk Redo procedures When is catheter ablation most successful? PsAF Symptom benefit Reduction in co-morbidity Patient choice Who is at most risk during catheter ablation? PsAF

Clinical characteristics of patients with persistent atrial fibrillation successfully treated by left atrial ablation Takahashi Y et al Circ Arrhythmia Electrophysiol 2010;3:465 471.

Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation AF duration Male Gender Heart failure Rostock et al, Heart Rhythm Vol 9, 2011

Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation? a meta-analysis D Ascenzo et al; International Journal of Cardiology 167 (2013) 1984 1989

The impact of age on the efficacy and safety of catheter ablation for longstanding persistent atrial fibrillation Xiao-Dong Zhang et al; International Journal of Cardiology 168 (2013) 2693 2698

16 Obstructive Sleep Apnoea (OSA) 720 consecutive pts Treated OSA was > 4hrs CPAP AF recurrence seen in: - 51% OSA vs 30% no OSA (p<0.0001) - 68% untreated vs 35% treated (p<0.0001) Neilan G et al. Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation. JAHA 2013.

Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: The importance of rhythm and rate control Nedios et al Heart Rhythm 2014;11:344 351

A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial) Ejection fraction NYHA class Hunter et al. Circ Arrhythm Electrophysiol. 2014;7:31-38.

Catheter Ablation of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Systematic Review and Meta- Analysis 1838 patients Mean EF 40% Anselmino et al; Circ Arrhythm Electrophysiol. Epub Sept 28, 2014;

Predictors of complications after AF Examples: ablation Female gender Increasing age HCM Institutional experience Bohnen M et al Heart Rhythm. 2011 Nov;8(11):1661-6 Hoyt et al Heart Rhythm. 2011 Dec;8(12):1869-74 Shah RU et al. J Am Coll Cardiol. 2012 Jan 10;59(2) Inoue K, Heart Rhythm. 2014 Aug 15

June 2014

How do you decide on rate versus rhythm control? i.e. who do you want to ablate? Highly symptomatic secondary to AF Short duration of AF Long duration of SR post DCCV Structurally normal heart Exceptions: young heart failure patients

Questions?